Massachusetts General Hospital Crohn's and Colitis Center

Boston, Massachusetts 02114

0 studies enrolling now · 5 studies all time

What they study most

Crohn's Disease, Ulcerative Colitis

Studies at this site

• Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis — Running, not enrolling
• Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease — Stopped early
• Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease — Completed
• Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis — Completed
• Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease — Completed